Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


09.09.2024

3 AJR Am J Roentgenol
1 Ann Surg Oncol
2 Arch Bronconeumol
3 BMC Cancer
1 Cancer
3 Cancer Lett
1 Cancer Res
2 Clin Cancer Res
1 Clin Lung Cancer
2 Clin Nucl Med
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Clin Invest
1 J Clin Oncol
1 Lancet Oncol
2 Lung Cancer
1 Lung Cancer (Auckl)
1 Oncologist
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LEE JE, Park KS, Kim YH, Song HC, et al
    Lung Cancer Staging Using Chest CT and FDG PET/CT Free-Text Reports: Comparison Among Three ChatGPT Large-Language Models and Six Human Readers of Varying Experience.
    AJR Am J Roentgenol. 2024 Sep 4. doi: 10.2214/AJR.24.31696.
    PubMed         Abstract available

  2. CHRISTENSEN JD, Prosper AE
    New Lung-RADS Statement: A Talk With Committee Members Dr Jared Christensen and Dr Ashley Prosper.
    AJR Am J Roentgenol. 2024;223:e2431561.
    PubMed        

  3. ISSA G, Beland MD
    Beyond the AJR: American College of Radiology TI-RADS Validation Study-Can We Perform Fine-Needle Aspiration of Even Fewer Nodules?
    AJR Am J Roentgenol. 2024;223:e2330693.
    PubMed        


    Ann Surg Oncol

  4. LIU J, Li D, Ma H, Li Y, et al
    Early Postoperative Patient-Reported Outcomes of Sarcopenia Versus Nonsarcopenia in Patients Undergoing Video-Assisted Thoracoscopic Surgery for Lung Cancer.
    Ann Surg Oncol. 2024 Aug 31. doi: 10.1245/s10434-024-16140.
    PubMed         Abstract available


    Arch Bronconeumol

  5. GONZALEZ J, Seijo LM, de-Torres JP, Benitez ID, et al
    Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00170.
    PubMed         Abstract available

  6. FORCADA BARREDA C, Fuentes Gago MG, Gomez Hernandez MT
    Subconjunctival Emphysema After Videothoracoscopic Segmentectomy.
    Arch Bronconeumol. 2024 May 4:S0300-2896(24)00138.
    PubMed        


    BMC Cancer

  7. WANG W, Zhang X, Gui P, Zou Q, et al
    SEPT9: From pan-cancer to lung squamous cell carcinoma.
    BMC Cancer. 2024;24:1105.
    PubMed         Abstract available

  8. YANG D, Yang Y, Zhao M, Ji H, et al
    Evaluation of the invasiveness of pure ground-glass nodules based on dual-head ResNet technique.
    BMC Cancer. 2024;24:1080.
    PubMed         Abstract available

  9. BEFFA ED, Lyberis P, Rosboch GL, Arezzo A, et al
    Study protocol for Near-infrared molecular imaging for lung cancer detection and treatment during mini-invasive surgery (phase II Trial) - (the RECOGNISE study).
    BMC Cancer. 2024;24:1078.
    PubMed         Abstract available


    Cancer

  10. NIERENGARTEN MB
    Durvalumab not cost-effective with current pricing strategies for stage III NSCLC: The drug remains inaccessible to many patients for whom it is indicated as a standard of care after chemoradiation.
    Cancer. 2024;130:3236.
    PubMed        


    Cancer Lett

  11. SUN SY
    Is tumor microenvironment important for targeted therapy in lung cancer?
    Cancer Lett. 2024 Sep 3:217203. doi: 10.1016/j.canlet.2024.217203.
    PubMed        

  12. XUE R, Li X, Yang L, Yang M, et al
    Evaluation and integration of cell-free DNA signatures for detection of lung cancer.
    Cancer Lett. 2024 Sep 2:217216. doi: 10.1016/j.canlet.2024.217216.
    PubMed         Abstract available

  13. HUANG L, Liu X, Chen Q, Yang J, et al
    TGF-beta-induced lncRNA TBUR1 promotes EMT and metastasis in lung adenocarcinoma via hnRNPC-mediated GRB2 mRNA stabilization.
    Cancer Lett. 2024;600:217153.
    PubMed         Abstract available


    Cancer Res

  14. CONNER SJ, Borges HB, Guarin JR, Gerton TJ, et al
    Obesity Induces Temporally Regulated Alterations in the Extracellular Matrix That Drive Breast Tumor Invasion and Metastasis.
    Cancer Res. 2024;84:2761-2775.
    PubMed         Abstract available


    Clin Cancer Res

  15. EL ZARIF T, Meador CB, Qiu X, Seo JH, et al
    Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling.
    Clin Cancer Res. 2024;30:3798-3811.
    PubMed         Abstract available

  16. CHOI Y, Dharia NV, Jun T, Chang J, et al
    Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors.
    Clin Cancer Res. 2024;30:3788-3797.
    PubMed         Abstract available


    Clin Lung Cancer

  17. LIU J, Yang Y, Wu D, Li H, et al
    Efficacy of Prophylactic Cranial Irradiation in Early to Mid-stage Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging.
    Clin Lung Cancer. 2024 Aug 13:S1525-7304(24)00160.
    PubMed         Abstract available


    Clin Nucl Med

  18. HUANG S, Dai H, Huang R
    Pulmonary Epithelial Myoepithelial Carcinoma on 18F-FDG PET/CT: A Case Report.
    Clin Nucl Med. 2024;49:e521-e522.
    PubMed         Abstract available

  19. WU H, Zhou Y, Dong A, Wang Y, et al
    Thoracic SMARCA4-Deficient Undifferentiated Tumor Mimicking Malignant Pleural Mesothelioma on FDG PET/CT.
    Clin Nucl Med. 2024 Jul 3. doi: 10.1097/RLU.0000000000005358.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  20. MACMANUS MP, Prins E, Xie J, Akhurst T, et al
    Dose-response relationships between radiation exposure, bone marrow function as measured by (18)F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Sep 2:S0360-3016(24)03290.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  21. KIM SH, Seong H, Lee J, Ahn HY, et al
    The role of local ablative therapy in patients with advanced invasive mucinous adenocarcinoma of the lung.
    J Cancer Res Clin Oncol. 2024;150:409.
    PubMed         Abstract available


    J Clin Invest

  22. REEVES MQ
    Mapping the transcriptional evolution of human metastatic breast cancer.
    J Clin Invest. 2024;134:e183971.
    PubMed         Abstract available


    J Clin Oncol

  23. LOVLY CM
    New Benchmark for Targeted Therapies in Lung Cancer: Median Progression-Free Survival for Lorlatinib in Advanced ALK+ Non-Small Cell Lung Cancer Surpasses 5 years.
    J Clin Oncol. 2024 Sep 4:JCO2401147. doi: 10.1200/JCO.24.01147.
    PubMed        


    Lancet Oncol

  24. GOURD E
    World's first lung cancer vaccine trial launched in the UK.
    Lancet Oncol. 2024 Aug 30:S1470-2045(24)00324.
    PubMed        


    Lung Cancer

  25. GRIT GF, van Geffen E, Malmberg R, van Leeuwen R, et al
    Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective.
    Lung Cancer. 2024;196:107950.
    PubMed         Abstract available

  26. PEETERS S, Lau K, Stefanidis K, Yasufuku K, et al
    New diagnostic and nonsurgical local treatment modalities for early stage lung cancer.
    Lung Cancer. 2024;196:107952.
    PubMed         Abstract available


    Lung Cancer (Auckl)

  27. ARTER ZL, Nagasaka M
    Redefining Recovery: The Transformative Impact of the ALINA Trial on Adjuvant Therapy for ALK-Positive Non-Small Cell Lung Cancer.
    Lung Cancer (Auckl). 2024;15:129-133.
    PubMed         Abstract available


    Oncologist

  28. FLOREZ N, Patel SP, Wakelee H, Bazhenova L, et al
    Proceedings of the 1st biannual bridging the gaps in lung cancer conference.
    Oncologist. 2024 Sep 5:oyae228. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  29. LAI GS, Chen CS, Cheng JC, Li JR, et al
    Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients.
    PLoS One. 2024;19:e0309941.
    PubMed         Abstract available

  30. LIN L, Deng L, Bao Y
    Identifying crucial lncRNAs and mRNAs in hypoxia-induced A549 lung cancer cells and investigating their underlying mechanisms via high-throughput sequencing.
    PLoS One. 2024;19:e0307954.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.